These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28193831)

  • 1. β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome.
    Benagiano M; Gerosa M; Romagnoli J; Mahler M; Borghi MO; Grassi A; Della Bella C; Emmi G; Amedei A; Silvestri E; Emmi L; Prisco D; Meroni PL; D'Elios MM
    J Immunol; 2017 Apr; 198(7):2640-2648. PubMed ID: 28193831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.
    Benagiano M; Borghi MO; Romagnoli J; Mahler M; Bella CD; Grassi A; Capitani N; Emmi G; Troilo A; Silvestri E; Emmi L; Alnwaisri H; Bitetti J; Tapinassi S; Prisco D; Baldari CT; Meroni PL; D'Elios MM
    Haematologica; 2019 Dec; 104(12):2519-2527. PubMed ID: 30872365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
    Rauch J; Salem D; Subang R; Kuwana M; Levine JS
    Front Immunol; 2018; 9():2836. PubMed ID: 30619248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site.
    Arai T; Yoshida K; Kaburaki J; Inoko H; Ikeda Y; Kawakami Y; Kuwana M
    Blood; 2001 Sep; 98(6):1889-96. PubMed ID: 11535526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
    Kuwana M
    Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
    Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
    Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
    Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome.
    Lin CC; Chang YK; Lin SC; Su JH; Chao YH; Tang KT
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques.
    Profumo E; Buttari B; Alessandri C; Conti F; Capoano R; Valesini G; Salvati B; Riganò R
    Int J Immunopathol Pharmacol; 2010; 23(1):73-80. PubMed ID: 20377996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic dendritic cells specific for β2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome.
    Zandman-Goddard G; Pierangeli SS; Gertel S; Blank M
    J Autoimmun; 2014 Nov; 54():72-80. PubMed ID: 24972993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β
    Sasaki T; Kobayashi K; Kita S; Kojima K; Hirano H; Shen L; Takenaka F; Kumon H; Matsuura E
    Autoimmun Rev; 2017 Feb; 16(2):159-167. PubMed ID: 27988435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism.
    Pengo V; Bison E; Ruffatti A; Iliceto S
    Thromb Res; 2008; 122(4):556-9. PubMed ID: 18328538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome.
    Kolyada A; Porter A; Beglova N
    Blood; 2014 Feb; 123(7):1090-7. PubMed ID: 24277078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
    Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
    Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.
    Grossi C; Capitani N; Benagiano M; Baldari CT; Della Bella C; Macor P; Tedesco F; Borghi MO; Maugeri N; D'Elios MM; Meroni PL
    Front Immunol; 2022; 13():1076167. PubMed ID: 36700193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
    Ostertag MV; Liu X; Henderson V; Pierangeli SS
    Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.